The present invention relates to pharmaceutical compositions containing compounds of formula 1whereinR1is H, C1-6-alkyl, C0-4-alkyl-C3-6-cycloalkyl, C1-6-haloalkyl;R2is H, C1-6-alkyl;Xis an anion selected from the group consisting of chloride or ½ dibenzoyltartratejis 1 or 2.processes for the preparation thereof, and their use to treat diseases connected with the CCR3 receptor